Logo

Novo Nordisk Collaborated with Microsoft to Advance Drug Discovery and Development Using AI

Share this
Novo Nordisk Collaborated with Microsoft to Advance Drug Discovery and Development Using AI

Novo Nordisk Collaborated with Microsoft to Advance Drug Discovery and Development Using AI

Shots:

  • The collaboration will combine Microsoft’s computational services, cloud, and AI with Novo Nordisk’s drug discovery, development, and data science capabilities to accelerate drug discovery and development. The collaboration will also accelerate Novo Nordisk’s R&D by using both companies’ expertise
  • In the first situation, AI will be used to automatically summarize and analysis of information from a wide array of sources to gain novel scientific insights
  • The companies will also use AI to develop models that can predict a person’s risk of developing atherosclerosis, identify biomarkers associated with the disease along with the drug targets

Ref:  Globenewswire | Image: Novo Nordisk 

Click here to­ read the full press release 

Neha

Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Related News/Articles

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions